Evaluation of consumer medication information dispensed in retail pharmacies

Archives of Internal Medicine

Volumn 170, Issue 15, 2010, Pages 1317-1324

  Winterstein, Almut G ^a   Linden, Stephan ^b   Lee, Abigail E ^b   Fernandez, Erica M ^b   Kimberlin, Carole L ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LISINOPRIL; METFORMIN;

ARTICLE; CONSUMER HEALTH INFORMATION; DRUG INFORMATION; FOOD AND DRUG ADMINISTRATION; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; CARDIOTONIC AGENTS; COMMUNITY PHARMACY SERVICES; COMPREHENSION; DRUG LABELING; HEALTH CARE REFORM; HUMANS; HYPOGLYCEMIC AGENTS; LISINOPRIL; METFORMIN; PATIENT EDUCATION AS TOPIC; PHARMACIES; READING; RETENTION (PSYCHOLOGY); UNITED STATES;

EID: 77955481527     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.263     Document Type: Article

References (19)

1. Pub L No. 104-180, 110 Stat 1593.
2. Svarstad BL, Mount JK. Evaluation of Written Prescription Information Provided in Community Pharmacies, 2001, final report to the US Department of Health and Human Services and the Food and Drug Administration. http://www.fda.gov /AboutFDA/CentersOffices/cder/ucm169753.htm. Accessed September 12, 2009.
3. Drug Safety and Risk Management Advisory Committee meeting, July 17, 2002. http://www.fda.gov/ohrms/dockets/ac/02/transcripts/3874T1.htm. Accessed September 12, 2009.
4. Guidance Document on Useful Written Consumer Medication Information (CMI), US Department of Health and Human Services and the Food and Drug Administration procedural. http://www.fda.gov/cder/guidance/7139fnl.htm. Accessed September 12, 2009.
5. Glucophage [package insert]. New York, NY: Bristol-Meyers Squibb; 2006. http: //packageinserts.bms.com/pi/pi-glucophage.pdf. Accessed September 12, 2009.
6. Prinivil [package insert]. Whitehouse Station, NJ: Merck & Co Inc; 2006. http: //www.merck.com/product/usa/pi-circulars/p/prinivil/prinivil-pi.pdf. Accessed September 12, 2009.
7. Clinical Pharmacology. http://www.clinicalpharmacology.com/?epm=2-1. Accessed November 2008.
8. Micromedex gateway. http://www.thomsonhc.com/home/dispatch. Accessed October 2008.
9. Drug Facts and Comparisons. St Louis, MO: JB Lippincott Co; 2008.
10. American Society of Hospital Pharmacists. AHFS Drug Information. Bethesda, MD: American Society of Hospital Pharmacists; 2008.
11. Lexi-Comp Web site. http://www.lexi.com/. Accessed October 2008.
12. AHFS Consumer Medication Information. http://www.ncbi.nlm.nih.gov/books /bv.fcgi?rid=medmaster. Accessed October 2008.
13. Clinical Pharmacology Patient Education. http://clinicalpharmacology.com/ ?epm=2-1. Accessed October 2008.
14. Mesmer HAE. Tools for Matching Readers to Texts: Research-Based Practices. New York, NY: Guilford Press; 2008.
15. Lauchman R. Plain Language: A Handbook for Writers in the U.S. Federal Government. Rockville, MD: Lauchman Group; 2008.
16. Shrank W, Avorn J, Rolon C, Shekelle P. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007;41(5):783-801. (Pubitemid 46752658)
17. Avorn J, Shrank WH. Communicating drug benefits and risks effectively: there must be a better way. Ann Intern Med. 2009;150(8):563-564.
18. Schwartz LM, Woloshin S, Welch HG. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med. 2009;150 (8):516-527.
19. McKinney R, Abernethy AP, Matchar DB, Wheeler JL. White paper: potential conflict of interest in the production of drug compendia. http://www.cms.hhs.gov /determinationprocess/downloads/id64TA.pdf. Accessed September 12, 2009.